$0.07
(Market cap
$305 Mln
Recently Viewed
Clear AllMarket cap
$305 Mln
Revenue (TTM)
$282 Mln
P/E Ratio
34.7
P/B Ratio
1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
Industry P/E
49.86
EV/EBITDA
5.7
Debt to Equity
0
Book Value
$--
EPS
$0.2
Face value
--
Shares outstanding
58,490,603
CFO
$182.17 Mln
EBITDA
$208.82 Mln
Net Profit
$9.70 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Materialise NV - ADR
| -5.0 | 6.8 | -8.6 | 2.2 | -12.2 | -31.1 | -3.3 |
|
BSE Sensex
| -8.7 | 2.7 | -5.2 | -2.4 | 8.6 | 9.8 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Materialise NV - ADR
| -21.2 | 7.1 | -25.3 | -63.1 | -56.0 | 196.1 | -8.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Materialise NV - ADR
|
5.3 | 304.7 | 281.6 | 14.7 | 7.9 | 5.8 | 34.7 | 1.0 |
| 3.5 | 304.4 | 146.3 | 14.1 | 0.9 | 2.5 | 45 | 0.5 | |
| 169.0 | 5,985.9 | 995.3 | 152.0 | 17.7 | 31.4 | 40.3 | 12.7 | |
| 5.4 | 166.0 | 1,191.8 | -409.8 | -17.9 | -24.9 | -- | 0.7 | |
| 0.6 | 57.2 | 64.1 | -66.1 | -11.8 | -115.5 | -- | 1.8 | |
| 8.6 | 8,890.1 | 12,894.4 | 4,100.2 | 0.0 | 10.2 | 13.7 | 1.5 | |
| 5.9 | 201.6 | 1,884.4 | 22.1 | 1.4 | 6.5 | 10.5 | 0.7 | |
| 37.2 | 6,310.4 | 1,700.2 | 340.8 | 11.4 | 52.3 | 20.2 | 8.4 | |
| 2.3 | 1,409.8 | 332.4 | 66.4 | 0.0 | 6.6 | 25.6 | 1.4 | |
| 11.3 | 1,263.0 | 6,118.7 | 77.7 | 1.0 | -- | 80.5 | 60.1 |
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and... Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium. Read more
Chief Executive Officer
Ms. Brigitte de Vet-Veithen
Chief Executive Officer
Ms. Brigitte de Vet-Veithen
Headquarters
Leuven
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Materialise NV - ADR is $5.28 (NASDAQ) as of 27-Apr-2026 11:34 EDT. Materialise NV - ADR has given a return of -12.19% in the last 3 years.
The P/E ratio of Materialise NV - ADR is 34.73 times as on 24-Apr-2026, a 30 discount to its peers’ median range of 49.86 times.
The P/B ratio of Materialise NV - ADR is 1.02 times as on 24-Apr-2026, a 80 discount to its peers’ median range of 5.01 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
44.22
|
1.28
|
|
2024
|
30.99
|
1.68
|
|
2023
|
57.73
|
1.64
|
|
2022
|
-244.82
|
2.27
|
|
2021
|
107.11
|
6.06
|
The 52-week high and low of Materialise NV - ADR are Rs 6.80 and Rs 4.78 as of 27-Apr-2026.
Materialise NV - ADR has a market capitalisation of $ 305 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Materialise NV - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.